6 | AnkyrinsIBA
09/2019
-
07/2011 |
5 | Pharmaceutical PreparationsIBA
01/2022
-
06/2012 |
5 | Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2015
-
04/2003 |
4 | Biological ProductsIBA
01/2021
-
03/2017 |
3 | LigandsIBA
03/2017
-
12/2008 |
3 | TubulinIBA
03/2013
-
05/2007 |
2 | Antitussive Agents (Antitussives)FDA Link
01/2021
-
04/2016 |
2 | NeuropeptidesIBA
01/2021
-
12/2010 |
2 | Irritants (Vesicants)IBA
09/2019
-
09/2012 |
2 | CarrageenanIBA
01/2019
-
07/2015 |
2 | Dinoprostone (PGE2)FDA Link
01/2019
-
07/2015 |
2 | Analgesics (Analgesic Drugs)IBA
01/2019
-
03/2017 |
2 | indoleIBA
12/2018
-
06/2009 |
2 | Formaldehyde (Formol)FDA Link
07/2015
-
02/2012 |
2 | TRPA1 Cation ChannelIBA
07/2015
-
03/2012 |
2 | benzothiopheneIBA
03/2013
-
05/2007 |
2 | 2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
09/2012
-
07/2011 |
2 | ThiazolesIBA
06/2012
-
01/2009 |
2 | acetamideIBA
03/2009
-
12/2008 |
2 | BAY 60-6583IBA
03/2009
-
12/2008 |
2 | Anti-Allergic Agents (Antiallergic Agents)IBA
01/2009
-
04/2003 |
2 | ColchicineFDA LinkGeneric
11/2008
-
05/2007 |
1 | Receptor-Interacting Protein Serine-Threonine KinasesIBA
01/2021 |
1 | Nociceptin ReceptorIBA
01/2021 |
1 | Caspase 3 (Caspase-3)IBA
01/2021 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2021 |
1 | NociceptinIBA
01/2021 |
1 | Proteins (Proteins, Gene)FDA Link
01/2021 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 |
1 | Small Molecule LibrariesIBA
10/2020 |
1 | Fetal Hemoglobin (Hemoglobin F)IBA
10/2020 |
1 | GlobinsIBA
10/2020 |
1 | Transient Receptor Potential ChannelsIBA
09/2019 |
1 | ibuprofen acyl glucuronideIBA
01/2019 |
1 | ZP120IBA
01/2019 |
1 | Ibuprofen (Motrin)FDA LinkGeneric
01/2019 |
1 | ChalconesIBA
12/2018 |
1 | decaneIBA
01/2018 |
1 | Adenosine Triphosphate (ATP)IBA
01/2018 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2018 |
1 | Anti-Anxiety Agents (Anxiolytics)IBA
03/2017 |
1 | Nootropic Agents (Nootropics)IBA
03/2017 |
1 | Citric Acid (Citrate)FDA LinkGeneric
04/2016 |
1 | Bronchodilator Agents (Bronchodilators)IBA
04/2016 |
1 | OzoneIBA
04/2016 |
1 | Bortezomib (Velcade)FDA Link
07/2015 |
1 | Dipyrone (Metamizole)IBA
07/2015 |
1 | propyphenazoneIBA
07/2015 |
1 | ThiophenesIBA
09/2014 |
1 | Methylnitronitrosoguanidine (MNNG)IBA
11/2013 |
1 | benzocycloheptapyridineIBA
03/2013 |
1 | Cannabinoid Receptor AgonistsIBA
07/2012 |
1 | Tubulin ModulatorsIBA
06/2012 |
1 | TRPC6 Cation ChannelIBA
06/2012 |
1 | pyrimidineIBA
03/2012 |
1 | ChlorineIBA
02/2012 |
1 | SmokeIBA
02/2012 |
1 | (1R,5S)- 4- methyl- 1- propan- 2- ylbicyclo(3.1.0)hex- 3- en- 2- oneIBA
02/2012 |
1 | Purinergic P1 Receptor AntagonistsIBA
01/2012 |
1 | CationsIBA
07/2011 |
1 | Cisplatin (Platino)FDA LinkGeneric
07/2011 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2011 |
1 | Acetaminophen (Paracetamol)FDA LinkGeneric
12/2010 |
1 | N-acetyl-4-benzoquinoneimine (NAPQI)IBA
12/2010 |